Guanoxan
Appearance
![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C10H13N3O2 |
Molar mass | 207.233g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Guanoxanis asympatholyticdrug that was marketed asEnvacarby Pfizer in the UK to treathigh blood pressure.It was not widely used and was eventually withdrawn from the market due to liver toxicity.[1][2]
References
[edit]- ^Broadley KJ (1996).Autonomic Pharmacology.CRC Press. p. 276.ISBN9780748405565.
- ^Wardell WM, Lasagna L (1975).Regulation and drug development.Washington: American Enterprise Institute for Public Policy Research. p.65.ISBN9780844731674.